CAPRICOR THERAPEUTICS, INC. Increase (Decrease) in Deferred Revenue
CAPRICOR THERAPEUTICS, INC. (CAPR) reported Increase (Decrease) in Deferred Revenue of $0 for the 12-month period ending 2018-12-31, per its 10-K filed 2019-03-29.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInDeferredRevenue · last filed 2019-03-29
- CAPRICOR THERAPEUTICS, INC. increase (decrease) in deferred revenue for the quarter ending 2018-12-31 was $0.00.
- CAPRICOR THERAPEUTICS, INC. increase (decrease) in deferred revenue for the quarter ending 2018-09-30 was $0.00.
- CAPRICOR THERAPEUTICS, INC. increase (decrease) in deferred revenue for the quarter ending 2018-06-30 was $0.00.
- CAPRICOR THERAPEUTICS, INC. increase (decrease) in deferred revenue for the quarter ending 2018-03-31 was $0.00.
- CAPRICOR THERAPEUTICS, INC. increase (decrease) in deferred revenue for fiscal 2018 was $0.00.
- CAPRICOR THERAPEUTICS, INC. increase (decrease) in deferred revenue for fiscal 2017 was -$1.37M.
- CAPRICOR THERAPEUTICS, INC. increase (decrease) in deferred revenue for fiscal 2016 was -$3.19M.
- CAPRICOR THERAPEUTICS, INC. increase (decrease) in deferred revenue for fiscal 2015 was -$3.78M, a 145.31% decline from fiscal 2014.
| Period end | Increase (Decrease) in Deferred Revenue 3 month | Increase (Decrease) in Deferred Revenue 6 month | Increase (Decrease) in Deferred Revenue 9 month | Increase (Decrease) in Deferred Revenue 12 month |
|---|---|---|---|---|
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-29 | $0.00 derived: sum of 2 quarters · filed 2019-03-29 | $0.00 derived: sum of 3 quarters · filed 2019-03-29 | $0.00 10-K · filed 2019-03-29 |
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-14 | $0.00 derived: sum of 2 quarters · filed 2018-11-14 | $0.00 10-Q · filed 2018-11-14 | $0.00 derived: sum of 4 quarters · filed 2019-03-29 |
| 2018-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-13 | $0.00 10-Q · filed 2018-08-13 | $0.00 derived: sum of 3 quarters · filed 2019-03-29 | $0.00 derived: sum of 4 quarters · filed 2019-03-29 |
| 2018-03-31 | $0.00 10-Q · filed 2018-05-14 | $0.00 derived: sum of 2 quarters · filed 2019-03-29 | $0.00 derived: sum of 3 quarters · filed 2019-03-29 | -$683.59K derived: sum of 4 quarters · filed 2019-03-29 |
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-29 | $0.00 derived: sum of 2 quarters · filed 2019-03-29 | -$683.59K derived: sum of 3 quarters · filed 2019-03-29 | -$1.37M 10-K · filed 2019-03-29 |
| 2017-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-14 | -$683.59K derived: sum of 2 quarters · filed 2018-11-14 | -$1.37M 10-Q · filed 2018-11-14 | -$2.05M derived: sum of 4 quarters · filed 2018-11-14 |
| 2017-06-30 | -$683.59K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-13 | -$1.37M 10-Q · filed 2018-08-13 | -$2.05M derived: sum of 3 quarters · filed 2018-08-13 | -$2.73M derived: sum of 4 quarters · filed 2018-08-13 |
| 2017-03-31 | -$683.59K 10-Q · filed 2018-05-14 | -$1.37M derived: sum of 2 quarters · filed 2018-05-14 | -$2.05M derived: sum of 3 quarters · filed 2018-05-14 | -$2.96M derived: sum of 4 quarters · filed 2018-05-14 |
| 2016-12-31 | -$683.60K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-22 | -$1.37M derived: sum of 2 quarters · filed 2018-03-22 | -$2.28M derived: sum of 3 quarters · filed 2018-03-22 | -$3.19M 10-K · filed 2018-03-22 |
| 2016-09-30 | -$683.60K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-14 | -$1.60M derived: sum of 2 quarters · filed 2017-11-14 | -$2.51M 10-Q · filed 2017-11-14 | -$3.42M derived: sum of 4 quarters · filed 2017-11-14 |
| 2016-06-30 | -$911.46K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-14 | -$1.82M 10-Q · filed 2017-08-14 | -$2.73M derived: sum of 3 quarters · filed 2017-08-14 | -$3.65M derived: sum of 4 quarters · filed 2017-08-14 |
| 2016-03-31 | -$911.46K 10-Q · filed 2017-05-15 | -$1.82M derived: sum of 2 quarters · filed 2017-05-15 | -$2.73M derived: sum of 3 quarters · filed 2017-05-15 | -$3.65M derived: sum of 4 quarters · filed 2017-05-15 |
| 2015-12-31 | -$911.46K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-16 | -$1.82M derived: sum of 2 quarters · filed 2017-03-16 | -$2.73M derived: sum of 3 quarters · filed 2017-03-16 | -$3.78M 10-K · filed 2017-03-16 |
| 2015-09-30 | -$911.46K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-14 | -$1.82M derived: sum of 2 quarters · filed 2016-11-14 | -$2.86M 10-Q · filed 2016-11-14 | -$3.91M derived: sum of 4 quarters · filed 2016-11-14 |
| 2015-06-30 | -$911.46K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-15 | -$1.95M 10-Q · filed 2016-08-15 | -$2.99M derived: sum of 3 quarters · filed 2016-08-15 | -$4.04M derived: sum of 4 quarters · filed 2016-08-15 |
| 2015-03-31 | -$1.04M 10-Q · filed 2016-05-13 | -$2.08M derived: sum of 2 quarters · filed 2016-05-13 | -$3.13M derived: sum of 3 quarters · filed 2016-05-13 | -$4.17M derived: sum of 4 quarters · filed 2016-05-13 |
| 2014-12-31 | -$1.04M derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-30 | -$2.08M derived: sum of 2 quarters · filed 2016-03-30 | -$3.13M derived: sum of 3 quarters · filed 2016-03-30 | $8.33M 10-K · filed 2016-03-30 |
| 2014-09-30 | -$1.04M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-13 | -$2.08M derived: sum of 2 quarters · filed 2015-11-13 | $9.37M 10-Q · filed 2015-11-13 | |
| 2014-06-30 | -$1.04M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-14 | $10.42M 10-Q · filed 2015-08-14 | ||
| 2014-03-31 | $11.46M 10-Q · filed 2015-05-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PUMA BIOTECHNOLOGY, INC. (PBYI) | United States | $0.507B | 15.53 |
| ARVINAS, INC. (ARVN) | United States | $0.510B | 58.38 |
| Ovid Therapeutics Inc. (OVID) | United States | $0.487B | -14.41 |
| ASSEMBLY BIOSCIENCES, INC. (ASMB) | United States | $0.481B | -13,053.96 |
| Evolus, Inc. (EOLS) | United States | $0.519B | -13.32 |
| CRESCENT BIOPHARMA, INC. (CBIO) | United States | $0.529B | -5.20 |
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B | |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 | |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |